MET and gastric cancer: MET was also explored as druggable target in GC (Lennerz et al. 2011; Shah et al. 2013; Teng et al. 2013; Hack et al. 2014; Jardim et al. 2014; Kang et al. 2014), and efficacy may depend on its expression pattern detected by immunohistochemistry and/or in situ hybridization (Hack et al. 2014).